返回 Agenda
Session 8 – Customer Engagement Programs
Session Chair(s)
Michael Richardson, MD, FFPM, FRCP
Senior Vice President, WorldWide Patient Safety
Bristol-Myers Squibb, United Kingdom
What are customer engagement programs and patient support programs (PSPs)? This session will examine key elements of these programs and how they can add value and support pharmacovigilance practices. Presenters will explore the operational challenges of setting up PSPs and managing safety information from these programs and one of the speakers will share a survey on industry best practices, regarding customer engagement programs and pharmacovigilance.
Speaker(s)
What are PSPs and Why Do We Do Them?
Coleman Gerstner
Eli Lilly and Company, United States
Director, Global Patient Support Program Strategy and Capabilities
Customer Engagement Programs: Survey on Industry Practices Regarding Pharmacovigilance
Jamie Portnoff
Truliant Consulting, United States
Partner, Co-Founder
PSPs from PV and Risk Management Perspective/Industry Experience
Vicki Edwards, RPh
Abbvie, United Kingdom
Vice President, Pharmacovigilance Excellence and International QPPV